- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Averitas Pharma, Inc.
Total 2708 results
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingAdvanced Cancer | Advanced MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingAge-Related Macular Degeneration | Geographic AtrophyUnited States, Italy, Latvia, France, Israel, Germany, Spain, Hungary, Brazil, Canada, Argentina, Colombia, Croatia, Australia, Austria, Belgium, Czechia
-
Astellas Pharma Global Development, Inc.CompletedInvasive Aspergillosis | Invasive MucormycosisUnited States, Belgium, Spain
-
Astellas Pharma Global Development, Inc.TerminatedReduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen ExtractionUnited States
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedRenal Impairment | Healthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedHealthy SubjectsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedTumors | Incurable Platinum Refractory Germ Cell TumorsUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Global Development, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.CompletedInvasive Fungal InfectionUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine
-
Astellas Pharma Global Development, Inc.CompletedFibromyalgiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedArthritis, RheumatoidUnited States, Poland, Czechia, Bulgaria, Hungary, Mexico
-
Astellas Pharma Global Development, Inc.TerminatedNon-hematologic Malignancies | Pharmacokinetics of ASP9853United States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States, Germany, Italy
-
Astellas Pharma Global Development, Inc.TerminatedPainful Diabetic Peripheral Neuropathy (PDPN)United States
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Astellas Pharma Global Development, Inc.WithdrawnSubjects With NSCLC With an EGFR Activating Mutation
-
Astellas Pharma Global Development, Inc.CompletedHealthy Subjects | Pharmacokinetics of ASP2408United States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Subjects | Pharmacokinetics of ASP4058 | Food Effect of ASP4058United States
-
Astellas Pharma Global Development, Inc.Not yet recruiting
-
Astellas Pharma Global Development, Inc.Recruiting
-
Astellas Pharma Global Development, Inc.RecruitingIntraoperative Ureter Visualization | Abdominolpelvic SurgeryUnited States
-
Astellas Pharma Global Development, Inc.RecruitingChronic Kidney Disease | Renal AnemiaRomania, Spain, Belgium, Germany, Norway, Slovakia, Denmark, Czechia, Lithuania, United Kingdom
-
Astellas Pharma Global Development, Inc.RecruitingIntraoperative Ureter Visualization | Abdominolpelvic SurgeryUnited States
-
Astellas Pharma Global Development, Inc.RecruitingPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Japan, Korea, Republic of
-
Astellas Pharma Global Development, Inc.RecruitingProstate Cancer | mCRPC | mCSPCUnited States
-
Astellas Pharma Global Development, Inc.RecruitingGastric Cancer | Pharmacokinetics of Zolbetuximab | Gastro-esophageal Junction (GEJ) Cancer | Pharmacokinetics of Oxaliplatin | Pharmacokinetics of Fluorouracil Bolus (5-FU)United States, Japan, Italy, Korea, Republic of, Taiwan, France
-
Astellas Pharma Global Development, Inc.CompletedHot Flashes | MenopauseUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingPancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States, Korea, Republic of, Japan, China, France, Turkey, Italy, Australia, Brazil, Ireland, Mexico, Spain, Taiwan
-
Astellas Pharma Global Development, Inc.AvailableMetastatic Gastroesophageal Junction (GEJ) Adenocarcinoma | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma Cancer | Metastatic Gastric Adenocarcinoma CancerUnited States, Germany
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedRenal Impairment | Healthy VolunteersUnited States, Japan
-
Astellas Pharma Global Development, Inc.CompletedRenal Impairment | Healthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) MutationTaiwan, Poland, Serbia, United States, Brazil, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Romania, Spain, Sweden, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Czechia, Canada, Latvia, Poland, Spain, Ukraine, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, United Kingdom, Latvia, Poland, Spain